Literature DB >> 17015447

Versatility and differential roles of cysteine residues in human prostacyclin receptor structure and function.

Jeremiah Stitham1, Scott R Gleim, Karen Douville, Eric Arehart, John Hwa.   

Abstract

Prostacyclin plays important roles in vascular homeostasis, promoting vasodilatation and inhibiting platelet thrombus formation. Previous studies have shown that three of six cytoplasmic cysteines, particularly those within the C-terminal tail, serve as important lipidation sites and are differentially conjugated to palmitoyl and isoprenyl groups (Miggin, S. M., Lawler, O. A., and Kinsella, B. T. (2003) J. Biol. Chem. 278, 6947-6958). Here we report distinctive roles for extracellular- and transmembrane-located cysteine residues in human prostacyclin receptor structure-function. Within the extracellular domain, all cysteines (4 of 4) appear to be involved in disulfide bonding interactions (i.e. a highly conserved Cys-92-Cys-170 bond and a putative non-conserved Cys-5-Cys-165 bond), and within the transmembrane (TM) region there are several cysteines (3 of 8) that maintain critical hydrogen bonding interactions (Cys-118 (TMIII), Cys-251 (TMVI), and Cys-202 (TMV)). This study highlights the necessity of sulfhydryl (SH) groups in maintaining the structural integrity of the human prostacyclin receptor, as 7 of 12 extracellular and transmembrane cysteines studied were found to be differentially indispensable for receptor binding, activation, and/or trafficking. Moreover, these results also demonstrate the versatility and reactivity of these cysteine residues within different receptor environments, that is, extracellular (disulfide bonds), transmembrane (H-bonds), and cytoplasmic (lipid conjugation).

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17015447     DOI: 10.1074/jbc.M604042200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  14 in total

1.  Comprehensive biochemical analysis of rare prostacyclin receptor variants: study of association of signaling with coronary artery obstruction.

Authors:  Jeremiah Stitham; Eric Arehart; Larkin Elderon; Scott R Gleim; Karen Douville; Zsolt Kasza; Kristina Fetalvero; Todd MacKenzie; John Robb; Kathleen A Martin; John Hwa
Journal:  J Biol Chem       Date:  2010-12-28       Impact factor: 5.157

2.  A profile of the residues in the second extracellular loop that are critical for ligand recognition of human prostacyclin receptor.

Authors:  Feng Ni; Shui-Ping So; Vanessa Cervantes; Ke-He Ruan
Journal:  FEBS J       Date:  2007-11-27       Impact factor: 5.542

Review 3.  Prostacyclin receptor regulation--from transcription to trafficking.

Authors:  C Midgett; J Stitham; K A Martin; J Hwa
Journal:  Curr Mol Med       Date:  2011-10       Impact factor: 2.222

4.  Evidence for the presence of a critical disulfide bond in the mouse EP3γ receptor.

Authors:  Jason D Downey; Charles R Sanders; Richard M Breyer
Journal:  Prostaglandins Other Lipid Mediat       Date:  2011-01-12       Impact factor: 3.072

Review 5.  Endothelium-mediated control of vascular tone: COX-1 and COX-2 products.

Authors:  Michel Félétou; Yu Huang; Paul M Vanhoutte
Journal:  Br J Pharmacol       Date:  2011-10       Impact factor: 8.739

6.  Differential roles of cysteine residues in the cellular trafficking, dimerization, and function of the high-density lipoprotein receptor, SR-BI.

Authors:  Jie Hu; Zhonghua Zhang; Wen-Jun Shen; Ann Nomoto; Salman Azhar
Journal:  Biochemistry       Date:  2011-11-29       Impact factor: 3.162

7.  Cellular cholesterol delivery, intracellular processing and utilization for biosynthesis of steroid hormones.

Authors:  Jie Hu; Zhonghua Zhang; Wen-Jun Shen; Salman Azhar
Journal:  Nutr Metab (Lond)       Date:  2010-06-01       Impact factor: 4.169

Review 8.  Prostacyclin receptor/thromboxane receptor interactions and cellular responses in human atherothrombotic disease.

Authors:  Scott Gleim; Zsolt Kasza; Kathleen Martin; John Hwa
Journal:  Curr Atheroscler Rep       Date:  2009-05       Impact factor: 5.113

9.  Human bile acid transporter ASBT (SLC10A2) forms functional non-covalent homodimers and higher order oligomers.

Authors:  Paresh P Chothe; Lindsay C Czuba; Robyn H Moore; Peter W Swaan
Journal:  Biochim Biophys Acta Biomembr       Date:  2017-12-01       Impact factor: 3.747

10.  Acceleration of cardiovascular disease by a dysfunctional prostacyclin receptor mutation: potential implications for cyclooxygenase-2 inhibition.

Authors:  Eric Arehart; Jeremiah Stitham; Folkert W Asselbergs; Karen Douville; Todd MacKenzie; Kristina M Fetalvero; Scott Gleim; Zsolt Kasza; Yamini Rao; Laurie Martel; Sharon Segel; John Robb; Aaron Kaplan; Michael Simons; Richard J Powell; Jason H Moore; Eric B Rimm; Kathleen A Martin; John Hwa
Journal:  Circ Res       Date:  2008-03-06       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.